Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System

Group I metabotropic glutamate (mGlu) receptors consists of mGlu1 and mGlu5 receptor subtypes. These receptors are widely distributed in the central nervous system (CNS), where they preferentially mediate facilitatory signalling in neurones and glial cells, mainly by favouring phospholipase (PLC) tr...

Full description

Bibliographic Details
Main Author: Anna Maria Pittaluga
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00295/full
id doaj-9502b230a56e44e8a2f855448adf3bfb
record_format Article
spelling doaj-9502b230a56e44e8a2f855448adf3bfb2020-11-24T22:49:08ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122016-08-01710.3389/fphar.2016.00295215882Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous SystemAnna Maria Pittaluga0Anna Maria Pittaluga1University of GenovaCenter of Excellence for Biomedical ResearchGroup I metabotropic glutamate (mGlu) receptors consists of mGlu1 and mGlu5 receptor subtypes. These receptors are widely distributed in the central nervous system (CNS), where they preferentially mediate facilitatory signalling in neurones and glial cells, mainly by favouring phospholipase (PLC) translocation. Based on the literature so far available, group I mGluRs are preferentially expressed at the postsynaptic side of chemical synapsis, where they participate in the progression of the chemical stimulus. Studies, however, have shown the presence of these receptors also at the presynaptic level, where they exert several functions, including the modulation of transmitter exocytosis. Presynaptic Group I mGluRs can be both autoreceptors regulating release of glutamate and heteroreceptors regulating the release of various transmitters, including GABA, dopamine, noradrenaline, and acetylcholine. While the existence of presynaptic release-regulating mGlu5 receptors is largely recognized, the possibility that mGlu1 receptors also are present at this level has been a matter of discussion for a long time. A large body of evidence published in the last decade, however, supports this notion. This review aims at revisiting the data from in vitro studies concerning the existence and the role of release-regulating mGlu1 receptors presynaptically located in nerve terminals isolated from selected regions of the CNS. The functional interaction linking mGlu5 and mGlu1 receptor subtypes at nerve terminals and their relative contributions as modulators of central transmission will also be discussed. We apologize in advance for omission in our coverage of the existing literature.http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00295/fullAutoreceptorspresynaptic receptorstransmitter releaseHeteroreceptorsmGlu1 receptors
collection DOAJ
language English
format Article
sources DOAJ
author Anna Maria Pittaluga
Anna Maria Pittaluga
spellingShingle Anna Maria Pittaluga
Anna Maria Pittaluga
Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System
Frontiers in Pharmacology
Autoreceptors
presynaptic receptors
transmitter release
Heteroreceptors
mGlu1 receptors
author_facet Anna Maria Pittaluga
Anna Maria Pittaluga
author_sort Anna Maria Pittaluga
title Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System
title_short Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System
title_full Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System
title_fullStr Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System
title_full_unstemmed Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System
title_sort presynaptic release-regulating mglu1 receptors in central nervous system
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2016-08-01
description Group I metabotropic glutamate (mGlu) receptors consists of mGlu1 and mGlu5 receptor subtypes. These receptors are widely distributed in the central nervous system (CNS), where they preferentially mediate facilitatory signalling in neurones and glial cells, mainly by favouring phospholipase (PLC) translocation. Based on the literature so far available, group I mGluRs are preferentially expressed at the postsynaptic side of chemical synapsis, where they participate in the progression of the chemical stimulus. Studies, however, have shown the presence of these receptors also at the presynaptic level, where they exert several functions, including the modulation of transmitter exocytosis. Presynaptic Group I mGluRs can be both autoreceptors regulating release of glutamate and heteroreceptors regulating the release of various transmitters, including GABA, dopamine, noradrenaline, and acetylcholine. While the existence of presynaptic release-regulating mGlu5 receptors is largely recognized, the possibility that mGlu1 receptors also are present at this level has been a matter of discussion for a long time. A large body of evidence published in the last decade, however, supports this notion. This review aims at revisiting the data from in vitro studies concerning the existence and the role of release-regulating mGlu1 receptors presynaptically located in nerve terminals isolated from selected regions of the CNS. The functional interaction linking mGlu5 and mGlu1 receptor subtypes at nerve terminals and their relative contributions as modulators of central transmission will also be discussed. We apologize in advance for omission in our coverage of the existing literature.
topic Autoreceptors
presynaptic receptors
transmitter release
Heteroreceptors
mGlu1 receptors
url http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00295/full
work_keys_str_mv AT annamariapittaluga presynapticreleaseregulatingmglu1receptorsincentralnervoussystem
AT annamariapittaluga presynapticreleaseregulatingmglu1receptorsincentralnervoussystem
_version_ 1725677162366763008